Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy

Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review for the U.S. Preventive Services Task Force

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

An Estrogen Model: The Relationship between Body Mass Index, Menopausal Status, Estrogen Replacement Therapy, and Breast Cancer Risk

(2012) Linda E. Green et al.   Computational and Mathematical Methods in Medicine

Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population

(2011) Joyce Noah-Vanhoucke et al.   CANCER

Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

(2010) E. Comen et al.   BREAST CANCER RESEARCH AND TREATMENT

Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

(2010) M. E. Mealiffe et al.   JNCI-Journal of the National Cancer Institute

Performance of Common Genetic Variants in Breast-Cancer Risk Models

(2010) Sholom Wacholder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation

(2009) Sonja V. Sorensen et al.   AMERICAN HEART JOURNAL

Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation

(2009) Amanda R. Patrick et al.  

Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states

(2009) Gary H. Lyman et al.   CLINICAL THERAPEUTICS

The Pre-Test Risk Stratified Cost-Effectiveness of 64-Slice Computed Tomography Coronary Angiography in the Detection of Significant Obstructive Coronary Artery Disease in Patients Otherwise Referred to Invasive Coronary Angiography

(2009) Florian P. Kreisz et al.   Heart Lung and Circulation

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States

(2009) Alberto Maud et al.   JOURNAL OF NEUROSURGERY

Value of Adding Single-Nucleotide Polymorphism Genotypes to a Breast Cancer Risk Model

(2009) Mitchell H. Gail   JNCI-Journal of the National Cancer Institute

Cost-effectiveness of abdominal aortic aneurysm repair based on aneurysm size

(2009) Kate C. Young et al.   JOURNAL OF VASCULAR SURGERY

Cost-Effectiveness of Hormone Therapy in the United States

(2009) Ingrid Lekander et al.   JOURNAL OF WOMENS HEALTH

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

(2009) Gilles Thomas et al.   NATURE GENETICS

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

(2009) Shahana Ahmed et al.   NATURE GENETICS

Cost-effectiveness of endarterectomy in patients with asymptomatic carotid artery stenosis

(2008) M. Henriksson et al.   BRITISH JOURNAL OF SURGERY

Cost-effectiveness of reducing wait times for cataract surgery in Ontario

(2008) Robert B. Hopkins et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk

(2008) Jacoba P. Greving et al.   CIRCULATION

Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

(2008) M. Garcia-Closas et al.   CLINICAL CANCER RESEARCH

Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US

(2008) Sandra L. Tunis et al.   CURRENT MEDICAL RESEARCH AND OPINION

The cost-effectiveness of thrombolysis administered by paramedics

(2008) Paul A. Scuffham et al.   CURRENT MEDICAL RESEARCH AND OPINION

Carotid Stenting versus Carotid Endarterectomy: Evidence Basis and Cost Implications

(2008) M.P. Janssen et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Cost-Utility Analysis of Antihypertensive Combination Therapy in Japan by a Monte Carlo Simulation Model

(2008) Ikuo SAITO et al.   HYPERTENSION RESEARCH

A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UK

(2008) Jonathan Karnon et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Tamoxifen for Breast Cancer Risk Reduction

(2008) Joy Melnikow et al.   MEDICAL CARE

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

(2008) Simon N Stacey et al.   NATURE GENETICS

Cost-Effectiveness of Stroke Unit Care Followed by Early Supported Discharge

(2008) Ömer Saka et al.   STROKE

Cost-Effectiveness of Primary versus Secondary Prophylaxis with Pegfilgrastim in Women with Early-Stage Breast Cancer Receiving Chemotherapy

(2008) Scott D. Ramsey et al.   VALUE IN HEALTH

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

(2008) Montserrat Garcia-Closas et al.   PLoS Genetics

Probabilistic Cost-Effectiveness Modeling of Different Breast Cancer Screening Policies in Slovenia

(2007) Klemen Rojnik et al.   VALUE IN HEALTH